These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21453206)

  • 21. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
    Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Community onset of methicillin resistant Staphylococcus aureus infections in previously healthy or health care-associated children in Argentina].
    Paganini H; Della MP; Muller B; Ezcurra G; Uranga M; Aguirre C; Kamiya M; Ensinck G; Miranda MR; Ciriaci C; Hernández C; Casimir L; Rial MJ; Schenonne N; Ronchi E; Rodríguez Mdel C; Aprile F; De Ricco C; Saito V; Vrátnica C; Pons L; Ernst A; Morinigo S; Toffoli M; Bosque C; Monzani V; Mónaco A; Pinheiro JL; López Mdel P; Maninno L; Sarkis C
    Rev Chilena Infectol; 2009 Oct; 26(5):406-12. PubMed ID: 19915748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community.
    Lee JC; Lee NY; Lee HC; Huang WH; Tsui KC; Chang CM; Lee CC; Chen PL; Wu CJ; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2012 Apr; 45(2):127-33. PubMed ID: 22041167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
    Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals.
    Rodríguez-Baño J; López-Prieto MD; Portillo MM; Retamar P; Natera C; Nuño E; Herrero M; del Arco A; Muñoz A; Téllez F; Torres-Tortosa M; Martín-Aspas A; Arroyo A; Ruiz A; Moya R; Corzo JE; León L; Pérez-López JA;
    Clin Microbiol Infect; 2010 Sep; 16(9):1408-13. PubMed ID: 19845694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone.
    Lee S; Song DY; Cho SH; Kwon KT
    Microb Drug Resist; 2014 Feb; 20(1):39-44. PubMed ID: 23941639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare associated infective endocarditis: a distinct entity.
    Siegman-Igra Y; Koifman B; Porat R; Porat D; Giladi M
    Scand J Infect Dis; 2008; 40(6-7):474-80. PubMed ID: 18584534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C; Shin SY;
    Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the clinical characteristics of diabetic and non-diabetic women with community-acquired acute pyelonephritis: a multicenter study.
    Kim Y; Wie SH; Chang UI; Kim J; Ki M; Cho YK; Lim SK; Lee JS; Kwon KT; Lee H; Cheong HJ; Park DW; Ryu SY; Chung MH; Pai H
    J Infect; 2014 Sep; 69(3):244-51. PubMed ID: 24854421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan.
    Wu HS; Wang FD; Tseng CP; Wu TH; Lin YT; Fung CP
    J Infect; 2012 Feb; 64(2):162-8. PubMed ID: 22101080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clinical features, antimicrobial susceptibility, serotype distribution and outcomes of patients with hospital- and community-associated invasive pneumococcal disease.
    Lin SH; Liao WH; Lai CC; Tan CK; Liao CH; Huang YT; Wang CY; Hsueh PR
    Int J Antimicrob Agents; 2010 Aug; 36(2):119-23. PubMed ID: 20472403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo susceptibility of ESBL producing Escherichia coli to ceftriaxone in children with acute pyelonephritis.
    Peco-Antić A; Paripović D; Buljugić S; Spasojević-Dimitrijeva B; Cvetković M; Laban-Nestorović S; Milosevski-Lomić G
    Srp Arh Celok Lek; 2012; 140(5-6):321-5. PubMed ID: 22826985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of antimicrobial resistance in patients with obstructive pyelonephritis associated with ureteral stones and uncomplicated pyelonephritis.
    Jang YR; Won J; Han J; Chung W; Ahn SJ
    Medicine (Baltimore); 2022 Aug; 101(34):e30376. PubMed ID: 36042611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China.
    Hu B; Ye H; Xu Y; Ni Y; Hu Y; Yu Y; Huang Z; Ma L
    Curr Med Res Opin; 2010 Jun; 26(6):1443-9. PubMed ID: 20394469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
    Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
    Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of microbiological and clinical characteristics based on SCCmec typing in patients with community-onset meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.
    Kuo SC; Chiang MC; Lee WS; Chen LY; Wu HS; Yu KW; Fung CP; Wang FD
    Int J Antimicrob Agents; 2012 Jan; 39(1):22-6. PubMed ID: 21982834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
    Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
    Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ; Smith N; Bradsher RW; Menon A
    Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.